PDCD1 and non-small cell lung carcinoma: Finally, Ferrara et al. compared in a retrospective study the frequency of HPD in patients with non-small cell lung cancer treated with anti-PD-1/PD-L1 or chemotherapy and showed that it is more common with PD-1/PD-L1 inhibitors but can still occur with chemotherapy treatment [137].